Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (411-420 of 412) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 412 results.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 42

Showing results (411-420 of 412) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 412 results.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 42